Enteral Systems at the Expert Level: Hidden Mechanisms, Physiological Paradoxes, and Clinical Myths
This expert, in-depth compendium of knowledge in advanced biopharmaceuticals, galenics, and clinical pharmacokinetics departs from trivial package insert recommendations (such as "don't chew, drink water") to explore non-obvious mechanisms, physiological paradoxes, and hidden pitfalls that even doctors and pharmacists rarely acknowledge.
Here is the knowledge about the maximum Information Gain index about enteral systems (gastro-resistant / enteric-coated):
1. The Pyloric Trap and the Migrating Motor Complex (MMC)
The biggest cognitive error is assuming that a swallowed capsule passes smoothly and predictably from the stomach to the intestine. From a physiological perspective, gastric emptying depends on the size of the object and the so-called feeding window.
- Pyloric sieve: During the digestion of food, the pylorus (the exit from the stomach) acts like a fine sieve - it passes into the duodenum only liquids and particles smaller than 1,5–2 mm in diameter.
- Gastric Retention: If a patient swallows a large, solid enteric-coated capsule after a full meal, the pylorus will close against it. The capsule will be trapped in the acid and subjected to mechanical crushing by the stomach. up to 6 to 10 hours! The capsule will only leave the stomach on an empty stomach, when phase III is initiated. Migratory Motor Complex (MMC) – the so-called “stomach broom”, a powerful contraction that sweeps away large objects, which does not occur when we eat.
- Solution – MUPS Systems: Pharmaceutical engineering has created multi-particular systems (Multiple Unit Pellet System). This is why modern medications (e.g., high-quality pancreatic enzymes or newer proton pump inhibitors) are capsules that deliberately dissolve in the stomach in 5 minutes. However, they release hundreds of enteric-coated micropellets (spheres <1,5 mm in diameter). Because they are so small, they bypass the closed pylorus and flow smoothly into the intestine with the chyme.
2. Chemical Intelligence of Polymers: The Deprotonation Phenomenon
The enteric-coated capsule does not measure time, but rather precisely responds to hydrogen ion concentration (pH). This is achieved through so-called intelligent polymers (e.g., methacrylic acid copolymers – Eudragit® series , or cellulose acetate phthalate).
- Their operation is based on carboxyl groups (-COOH)In the corrosive, acidic pH of the stomach (1.0–3.0), these groups remain protonated (non-ionized). The polymer is completely hydrophobic—it repels water like hard plastic.
- When the drug enters the duodenum and the pH rises above a specific threshold (the polymer's pKa value), a hydrogen ion is cleaved (deprotonated to the -COO⁻ anion). In a fraction of a second, the polymer acquires an electrical charge, becomes extremely hydrophilic, absorbs water, and explodes, releasing the drug.
Engineers can program disintegration with a precision of up to several centimeters: Eudragit L breaks at pH > 5.5 (duodenum), and Eudragit S only at pH > 7.0 (terminal ileum).
3. The Disaster of Polypharmacy: The Paradox of PPIs and Achlorhydria
This is one of the most dangerous, hidden clinical phenomena – so-called premature breakdown of the capsule in vivo . The capsules are designed for a healthy stomach (pH 1.5–2.0). What happens when the patient is elderly (natural loss of stomach acid – achlorhydria) or chronically takes heartburn medications (proton pump inhibitors, e.g., omeprazole, pantoprazole)?
These drugs artificially raise the stomach's pH to a value of 4.0–6.0 . Under these conditions, the ingested enteric-coated capsule "reads" the environment as the intestine and dissolves in the stomach . This leads to the complete destruction of the sensitive substance (e.g., expensive probiotics) by gastric enzymes or to severe localized burns of the mucosa caused by the irritant.
4. Alcohol-Induced Dose Dumping (AIDD)
Most people believe that drug interactions with alcohol occur in the liver. In the case of enteric-coated capsules, the mechanism is purely physicochemical and occurs directly in the stomach. Methacrylic polymers are completely insensitive to hydrochloric acid but exhibit excellent solubility in ethanol.
Consuming high-proof alcohol soon after taking enteric-coated medication acts as a powerful solvent. organicThe coating is chemically washed away, leading to a sudden, uncontrolled release of the entire dose of the drug in the stomach (so-called Dose Dumping). For potent modified-release drugs (e.g., opioids, neurological drugs), this results in a powerful, toxic dose impact into the bloodstream.
5. The Microbiome Trap and the Ghost Pill Phenomenon
If medicine wants to deliver a drug to the very end of the digestive tract (e.g. mesalazine in Crohn's disease), it uses polymers that break at pH > 7.0 (because this is the pH at the end of the small intestine).
Physiological catch: After crossing the ileocecal valve and entering the large intestine, the pH... unexpectedly drops drastically (to around 5.5-6.0). Why? Because the trillions of bacteria living there ferment food waste into short-chain fatty acids (SCFAs – e.g., butyric acid, propionic acid). If the capsule "missed" the narrow window in the ileum and didn't have time to dissolve, its shell hardens again upon entering the more acidic colon! The capsule is excreted intact in the stool (in pharmaceutical jargon, this is called a ghost pill ).
Next-Gen Technology (Triggered by Microbiota): State-of-the-art colon-targeting systems abandon pH sensors. Instead, they use coatings made of polysaccharides or azo-linked polymers. These coatings are completely resistant to acids and human enzymes. They travel intact until they reach the large intestine, where they are physically "eaten" by enzymes (e.g., azoreductases) produced exclusively by local anaerobic bacteria.
6. The Myth of Stomach Protection and the "Enteropathy Shift"
It is widely believed that enteric-coated acetylsalicylic acid (so-called cardiological doses, e.g., Acard, Polocard ) or enteric-coated NSAIDs (e.g., diclofenac) completely protect against ulcers. This is a pharmacological half-truth.
NSAIDs cause ulcers primarily systemically – they are absorbed into the bloodstream and block the COX-1 enzyme, essential for the production of protective gastric mucus, throughout the body. Worse still, recent studies using endoscopic capsules with a camera (VCE) have revealed that enteric-coated formulations often fail to solve the problem, but merely shift it anatomically lower . The release of the concentrated, irritating drug in the duodenum causes so-called NSAID-induced enteropathy in many patients – difficult-to-diagnose microbleeds and ulceration of the small intestine (where a traditional gastroscope simply cannot reach).
7. The Supplement Industry Illusion: DRcaps® is NOT an enteral system
The term "enteric-coated capsule" is commonly misused in the probiotic and supplement industry. True enteric-coating is expensive and kills bacteria with high temperatures. Manufacturers often use modern, vegan DRcaps® capsules (made from HPMC with added gellan gum).
From the point of view of the restrictive European Pharmacopoeia (Ph.Eur.), these are not true enteric-coated ( Gastro-resistant ) forms. They are delayed-release ( Delayed Release ) forms.
The difference is fundamental: a true polymer must survive in concentrated hydrochloric acid for a full two hours without releasing moisture. In vitro tests, DRcaps only swell and burst after about 45–50 minutes. If you take such a supplement with food (see point 1 – stomach entrapment), the capsule will disintegrate in the acid long before reaching the intestine, and the valuable probiotic strains will be irreversibly lost. True protection of sensitive substances requires microencapsulation technology (coating each particle individually), not just a seemingly hard outer shell.
